Literature DB >> 12547536

Screening interval for retinopathy in type 2 diabetes.

Ronald Klein1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12547536     DOI： 10.1016/S0140-6736(03)12317-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Causes of preventable visual loss in type 2 diabetes mellitus: an evaluation of suboptimally timed retinal photocoagulation.

Authors:  Rodney A Hayward; Claude Cowan; Veda Giri; Mary G Lawrence; Fatima Makki
Journal:  J Gen Intern Med       Date:  2005-05       Impact factor: 5.128

2.  Standards of medical care in diabetes--2009.

Authors: 
Journal:  Diabetes Care       Date:  2009-01       Impact factor: 19.112

3.  Standards of medical care in diabetes--2010.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

4.  Six-year retrospective follow-up study of safe screening intervals for sight-threatening retinopathy in patients with diabetes mellitus.

Authors:  Enrique Soto-Pedre; Maria Concepcion Hernaez-Ortega; José Antonio Vázquez
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

Review 5.  Screening Intervals for Diabetic Retinopathy and Implications for Care.

Authors:  Peter H Scanlon
Journal:  Curr Diab Rep       Date:  2017-09-05       Impact factor: 4.810

Review 6.  The Evolution of Diabetic Retinopathy Screening Programmes: A Chronology of Retinal Photography from 35 mm Slides to Artificial Intelligence.

Authors:  Josef Huemer; Siegfried K Wagner; Dawn A Sim
Journal:  Clin Ophthalmol       Date:  2020-07-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.